These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31119863)

  • 1. Effectiveness of a hepatitis B vaccination program at two tertiary hemodialysis centers.
    Kufta L; Shalansky KF; Jastrzebski J; Lau W
    Hemodial Int; 2019 Jul; 23(3):348-355. PubMed ID: 31119863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response after vaccination with recombinant hepatitis surface antigen in maintenance hemodialysis patients and healthy controls.
    Allegra V; Vasile A; Maschio M; Mengozzi G
    Nephron; 1992; 61(3):339-40. PubMed ID: 1386908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive factors for anti-HBs status after 1 booster dose of hepatitis B vaccine.
    Lu IC; Jean MC; Lin CW; Chen WH; Perng DS; Lin CW; Chuang HY
    Medicine (Baltimore); 2016 Sep; 95(39):e5023. PubMed ID: 27684874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B Vaccination Response in Hemodialysis Patients: The Impact of Dialysis Shift.
    Han M; Ye X; Rao S; Williams S; Thijssen S; Hymes J; Maddux FW; Kotanko P
    Blood Purif; 2021; 50(4-5):628-635. PubMed ID: 33508838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative long term immunogenicity of two recombinant hepatitis B vaccines and the effect of a booster dose given after five years in a low endemicity country.
    Duval B; Gîlca V; Boulianne N; De Wals P; Massé R; Trudeau G; De Serres G
    Pediatr Infect Dis J; 2005 Mar; 24(3):213-8. PubMed ID: 15750456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity of hepatitis B vaccine among hemodialysis patients: effect of revaccination of non-responders and duration of protection.
    Chaves SS; Daniels D; Cooper BW; Malo-Schlegel S; Macarthur S; Robbins KC; Kobetitsch JF; McDaniel A; D'Avella JF; Alter MJ
    Vaccine; 2011 Dec; 29(52):9618-23. PubMed ID: 22044739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole treatment enhances protective antibody response to hepatitis B vaccination in hemodialysis patients.
    Kayataş M
    Artif Organs; 2002 Jun; 26(6):492-6. PubMed ID: 12072104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity of Augmented Compared With Standard Dose Hepatitis B Vaccine in Pediatric Patients on Dialysis: a Midwest Pediatric Nephrology Consortium Study.
    Misurac JM; VanDeVoorde RG; Kallash M; Iorember FM; Luckritz KE; Rheault MN; Jetton JG; Turman MA; Kapur G; Twombley KE; Hashmat S; Weaver DJ; Leiser JD; Nailescu C
    Clin J Am Soc Nephrol; 2017 May; 12(5):772-778. PubMed ID: 28270432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of hepatitis B immunity in hemodialysis patients acquired either naturally or after vaccination.
    Tsouchnikas I; Dounousi E; Xanthopoulou K; Papakonstantinou S; Thomoglou V; Tsakiris D
    Clin Nephrol; 2007 Oct; 68(4):228-34. PubMed ID: 17969490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.
    Wang ZZ; Gao YH; Lu W; Jin CD; Zeng Y; Yan L; Ding F; Li T; Liu XE; Zhuang H
    Hum Vaccin Immunother; 2017 Apr; 13(4):909-915. PubMed ID: 27874311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy.
    Bagheri-Jamebozorgi M; Keshavarz J; Nemati M; Mohammadi-Hossainabad S; Rezayati MT; Nejad-Ghaderi M; Jamalizadeh A; Shokri F; Jafarzadeh A
    Hum Vaccin Immunother; 2014; 10(12):3731-6. PubMed ID: 25483689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HBs antibody persistence following primary vaccination with an investigational AS02(v)-adjuvanted hepatitis B vaccine in patients with renal insufficiency.
    Surquin M; Tielemans C; Nortier J; Jadoul M; Peeters P; Ryba M; Roznovsky L; Domán J; Barthelemy X; Crasta PD; Messier M; Houard S
    Hum Vaccin; 2011 Sep; 7(9):913-8. PubMed ID: 21892006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B vaccination: addressing a drug-related problem in hemodialysis outpatients with a collaborative initiative.
    Elwell RJ; Neumann M; Manley HJ; Carpentier L; Bailie GR
    Nephrol Nurs J; 2003 Jun; 30(3):310-3. PubMed ID: 12861899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Salama II; Sami SM; Salama SI; Rabah TM; El Etreby LA; Abdel Hamid AT; Elmosalami D; El Hariri H; Said ZN
    Vaccine; 2016 Apr; 34(16):1904-8. PubMed ID: 26930367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune persistence 17 to 20 years after primary vaccination with recombination hepatitis B vaccine (CHO) and the effect of booster dose vaccination.
    Zhao YL; Han BH; Zhang XJ; Pan LL; Zhou HS; Gao Z; Hao ZY; Wu ZW; Ma TL; Wang F; Li Q; Bi SL; Ma JC
    BMC Infect Dis; 2019 May; 19(1):482. PubMed ID: 31146699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of a triple antigen and a single antigen recombinant vaccine for adult hepatitis B vaccination.
    Young MD; Gooch WM; Zuckerman AJ; Du W; Dickson B; Maddrey WC
    J Med Virol; 2001 Jul; 64(3):290-8. PubMed ID: 11424117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of hepatitis B vaccine in high-risk young adults with waning immunity.
    Posuwan N; Vorayingyong A; Jaroonvanichkul V; Wasitthankasem R; Wanlapakorn N; Vongpunsawad S; Poovorawan Y
    PLoS One; 2018; 13(8):e0202637. PubMed ID: 30125298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term evaluation of immune response to hepatitis B vaccine in 136 patients undergoing hemodialysis].
    Pin M; Compte MT; Angelet P; Gállego C; Gutiérrez C; Martinez Vea A
    Nefrologia; 2009; 29(5):415-20. PubMed ID: 19820753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China.
    Wu W; Lv J; Liu J; Yan B; Feng Y; Xu A; Zhang L
    Hum Vaccin Immunother; 2018; 14(10):2485-2490. PubMed ID: 29993330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody and immune memory persistence after vaccination of preadolescents with low doses of recombinant hepatitis B vaccine.
    Gilca V; De Serres G; Boulianne N; De Wals P; Murphy D; Trudeau G; Deceuninck G; Massé R; Duval B
    Hum Vaccin; 2010 Feb; 6(2):212-8. PubMed ID: 19946212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.